The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Albert L. Lehninger sits on this spectrum.
This scientist: 243 publications — 65th percentile
65% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Albert L. Lehninger sits on this spectrum.
This scientist: 88 D-Index — 87th percentile
87% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Albert L. Lehninger is affiliated with the Johns Hopkins University School of Medicine in the United States. Their research primarily focuses on the fields of biochemistry, genetics, molecular biology, and chemistry. Within these fields, key subfields of study include molecular biology and organic chemistry.
The scientist's research extensively covers topics related to mitochondrial function and pathology, coenzyme Q10 studies and effects, as well as free radicals and antioxidants. These topics underpin much of their published work and reflect ongoing interests in cellular bioenergetics and oxidative processes.
Lehninger's recent publications include the paper titled "Reprint of: Ubisemiquinone Is the Electron Donor for Superoxide Formation by Complex III of Heart Mitochondria," published in 2022 in the journal Archives of Biochemistry and Biophysics. This publication focuses on mitochondrial mechanisms relevant to electron transport and reactive oxygen species generation.
Their frequent coauthors include:
Publication venues where Lehninger's work has appeared include:
Lehninger contributes to a specialized area of biochemical research that examines the interplay between mitochondrial enzymes and oxidative molecules. Their work on coenzyme Q10 and its effects, as well as investigations into free radicals and antioxidant mechanisms, positions them within a targeted niche of molecular biology and bioenergetics research.
Albert Lester Lehninger
Julio F. Turrens;Adolfo Alexandre;Adolfo Alexandre;Albert L. Lehninger
Albert L. Lehninger
A L Lehninger
Albert Lester Lehninger
Albert L. Lehninger;Ernesto Carafoli;Carlo S. Rossi
John A. Sibley;Albert L. Lehninger
William E. Jacobus;Albert L. Lehninger
Carlo Stefano Rossi;Carlo Stefano Rossi;Albert L. Lehninger;Albert L. Lehninger
Albert L. Lehninger
Albert L. Lehninger;Anibal Vercesi;Enitan A. Bababunmi
John W. Greenawalt;Carlo S. Rossi;Albert L. Lehninger
Eugene P. Kennedy;Albert L. Lehninger
Albert L. Lehninger;LeMar F. Remmert
Albert L. Lehninger;H.C. Sudduth;James B. Wise
G L Becker;G Fiskum;A L Lehninger
Albert Lester Lehninger
Gary Fiskum;Susan W. Craig;Glenn L. Decker;Albert L. Lehninger
Ulrich Hopfer;Albert L. Lehninger;Thomas E. Thompson
T L. Spencer;A L. Lehninger
If you think any of the details on this page are incorrect, let us know.
Meijo University
University of Minnesota
Clínic Barcelona
Sir Charles Gairdner Hospital
Royal Holloway University of London
Delft University of Technology
Northeastern University
Baylor College of Medicine
National Autonomous University of Mexico
University of Wisconsin–Madison
Technical University of Munich
University of Bari Aldo Moro
University of Notre Dame
Bowling Green State University
University of Strasbourg
Boston University
